NICE has issued draft final guidance recommending Nucala as an [...]

GSK announced that the European Commission has approved Exdensur (depemokimab) [...]

GlaxoSmithKline Biologicals (GSK) has advanced its net-zero ambitions at its [...]

Ochre Bio has completed the research phase of its collaboration [...]

Phase 3 data for GSK’s depemokimab appear to support the [...]

RNA therapeutics developer Ochre Bio has appointed Dr Elaine Sullivan [...]